Eli Lilly’s shares have surged 750 per cent over five years. Novo Nordisk’s are up about 360 per cent in the same period.

WHAT TO KNOW ABOUT GLP-1 SHORTAGES — It’s been a busy week in the diabetes and weight-loss drug world as Eli Lilly renews its push to shut down the compounding of its tirzepatide products and the ...

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say ...

Spinach, green tea, apples, celery, asparagus, coffee and berries are all good examples of foods high in polyphenols - which ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...

When it came to deciding what kinds of foods Vital Pursuit would sell, the team turned to another Nestlé brand, Life Cuisine, for inspiration. Life Cuisine was rolled out in 2020 as a sibling brand to ...

Ivím Health, a leader in telehealth-based weight management, has announced an innovative partnership with Klarna to enhance ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...